UA106748C2
(en )
2014-10-10
Proline derivatives as cathepsin inhibitors
MX2008001799A
(en )
2008-04-16
Pharmaceutical composition comprising a dpp-iv inhibitor.
ZA200808530B
(en )
2009-12-30
Pharmaceutical composition for external use
HK1136968A1
(en )
2010-07-16
Novel pharmaceutical composition
ZA200808531B
(en )
2009-12-30
Pharmaceutical composition for external use
EP2116242A4
(en )
2013-02-13
New pharmaceutical composition
GB0610322D0
(en )
2006-07-05
Novel pharmaceutical compositions
GB0608724D0
(en )
2006-06-14
Novel Pharmaceutical Compositions
PT2966175T
(en )
2019-06-27
Pharmaceutical compositions containing cortexolone-17-alpha-propionate
PL2170292T3
(en )
2014-06-30
Tableted compositions containing atazanavir
MX2009008249A
(en )
2009-08-12
Pharmaceutical composition comprising a campothecin derivative.
UA96476C2
(en )
2011-11-10
Pharmaceutical composition comprising irbesartan
HK1131156A1
(en )
2010-01-15
Novel morphine derivatives
UA27344U
(en )
2007-10-25
Use of pollentar pharmaceutical composition as cerebroprotective agent
UA27272U
(en )
2007-10-25
Use of yakton as cardioprotector
HU0700755D0
(en )
2008-01-28
Pharmaceutical compositions containing capsaicionid
UA27723U
(en )
2007-11-12
7-? -hydroxy- ? -(2',4'-dichlorophenoxy)-propyl-8-n-(n'-?-hydroxyethyl)-piperazino-3- methylxanthine revealing hypocholesteremic action
UA29770U
(en )
2008-01-25
Use of migrepin as analgesic substance
UA40770U
(en )
2009-04-27
use of interleukine-1 receptor antagonist as cardioprotective agent
UA41922U
(en )
2009-06-10
Use of altan as radioprotector
UA35660U
(en )
2008-09-25
Use of antihomotoxic preparations as cytoprotectors
UA36194U
(en )
2008-10-10
Use of quercetin as hepatoprotector
UA37933U
(en )
2008-12-10
Use of amcexol as anti-inflammatory substance
AP2007004090A0
(en )
2007-08-31
Novel pharmaceutical composition
GB0701367D0
(en )
2007-03-07
Novel pharmaceutical compositions